Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Biora Therapeutics, Inc. - Common Stock
(NQ:
BIOR
)
1.630
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
0
Open
1.630
Bid (Size)
1.390 (1)
Ask (Size)
1.660 (2)
Prev. Close
1.630
Today's Range
1.630 - 1.630
52wk Range
1.430 - 19.90
Shares Outstanding
4,063,081
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2024 Financial Results
November 14, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics's Earnings Outlook
November 13, 2024
Via
Benzinga
Performance
YTD
-87.74%
-87.74%
1 Month
-63.53%
-63.53%
3 Month
-75.23%
-75.23%
6 Month
-67.20%
-67.20%
1 Year
-88.10%
-88.10%
More News
Read More
Biora Therapeutics to Report Third Quarter 2024 Financial Results and Provide Corporate Update
November 07, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's Intraday Session
October 29, 2024
Via
Benzinga
Earnings Scheduled For November 14, 2024
November 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 29, 2024
Via
Benzinga
Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
October 29, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Shares Progress on Smaller BioJet™ Clinical Device with Largest Payload of any Ingestible Injectable at the 14th Annual PODD Meeting
October 28, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Reveal 00-Size BioJet™ Device at the 14th Annual Partnership Opportunities in Drug Delivery Meeting
October 14, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Tuesday's After-Market Session
October 08, 2024
Via
Benzinga
Biora Therapeutics to Present at the 19th Annual Peptide Therapeutics Symposium
October 07, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Award-Winning Abstract to be Presented at American College of Gastroenterology Annual Scientific Meeting 2024
September 30, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Achieves ISO 13485 Certification
September 09, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Positive Nasdaq Listing Decision
August 28, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Present at H.C. Wainwright 26th Annual Global Investment Conference
August 26, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
BIOR Stock Earnings: Biora Therapeutics Beats EPS for Q2 2024
August 12, 2024
Via
InvestorPlace
Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2024 Financial Results
August 12, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Funding Agreement with Existing Investors
August 12, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Report Second Quarter 2024 Financial Results and Provide Corporate Update
August 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Participate in Canaccord Genuity 44th Annual Growth Conference
August 06, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
July 18, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
July 08, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
July 01, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
12 Health Care Stocks Moving In Monday's After-Market Session
June 17, 2024
Via
Benzinga
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
June 11, 2024
From
Biora Therapeutics, Inc.
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.